Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It offers functional skincare products, medical dressings and devices, and functional food products under the KOMFYMED, Collgene, Ke Yu, SKIGIN, and other brands. The company also develops and manufactures rare ginsenosides technology-based functional food products. In addition, it provides aesthetic services. The company was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
Frequently asked questions
What sector does Giant Biogene Holding Co Ltd (2367) operate in?
Giant Biogene Holding Co Ltd belongs to the Consumer Staples sector and operates in the Household & Personal Products industry.
What is Giant Biogene Holding Co Ltd (2367) current stock price?
As of the latest data, Giant Biogene Holding Co Ltd stock price is HK$24.66, with a previous close of HK$24.26. Giant Biogene Holding Co Ltd gained HK$0.40 in the last trading session, representing a 1.65% increase.
What is Giant Biogene Holding Co Ltd (2367) current market capitalization?
Giant Biogene Holding Co Ltd market cap is approximately 26.18 billion.
What is Giant Biogene Holding Co Ltd (2367) EBITDA?
Giant Biogene Holding Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 959.58 million.
Does Giant Biogene Holding Co Ltd (2367) pay dividends?
Yes. Giant Biogene Holding Co Ltd pays annual dividends with an annualized yield of 5.63% and an estimated annual payout of HK$1.39 per share.
When is the next ex-dividend date for Giant Biogene Holding Co Ltd (2367)?
The next ex-dividend date is scheduled for June 01, 2027.
What is Giant Biogene Holding Co Ltd (2367) beta (volatility) score?
Giant Biogene Holding Co Ltd has a beta of 0.735, indicating lower volatility than the overall market.
